Ryan Clarke is the founding CEO of Syntax Bio and currently serving as the CTO. Ryan was trained as a developmental biologist with a specialty in CRISPR systems before launching Syntax, which has built an epigenetic programming system termed Cellgorithms for controlling stem cell fates for cell therapy applications.  

‍